Strengthening HPV Vaccination Coverage, Data Quality, and Communication in Europe with project PERCH

Home

Related articles

Anal cancer and HPV: a history of awareness and stigma. Interview with Lillian Kreppel

L Kreppel
Experience of Ampfire self-sampling technology in screening for cervical cancer in Guatemala

F Palma, M Bunker-Alberts, M Miskell, AB Penados, R Godfrey
Turning the tide: recommendations to increase cervical cancer screening among under-screened women

ACCESS International Consensus Group
The Ampfire HPV testing for HPV detection and genotyping in formalin-fixed paraffin-embedded oropharyngeal cancer samples

S Paytubi, MA Pavón
The Delhi Declaration on the elimination of cervical cancer and the reduction of HPV-associated cancers

NK Arora, D Waheed, A Vorsters
The New Zealand “unfortunate experiment” 40 years back: ethical lessons for the younger generations

RW Jones
Risk-based screening for cervical cancer in Europe

R Donken, C Robles, J Berkhof
Global partners cheer progress towards eliminating cervical cancer and underline challenges

World Health Organization (WHO), news release, November 17th 2023.
HPV vaccination after conization

M Jentschke, J Kampers, P Hillemanns
Immunogenicity and Safety of the 9-Valent Human Papillomavirus Vaccine in Solid Organ Transplant Recipients and Adults Infected With HIV

L Boey, M Roelants, C Vandermeulen
Cervical cancer and HIV

LF Tanaka, D Stelzle, SJ Klug
HPV vaccine uptake among gay, bisexual, and other men who have sex with men in major Canadian cities

C Chambers, R Grewal, AN Burchell
Performance of an affordable urine self-sampling method for human papillomavirus detection in Mexican women

RG Hernández, LS León Maldonado, J Salmerón
EU Joint Action on HPV Vaccination boosts HPV-related disease elimination plan

G Finnegan
Auditing HPV-based cervical cancer screening

LS Arroyo Mühr, M Hortlund, J Dillner
Introducing AmpFire HPV testing in cervical precancer screening activities: experience from Battor, Ghana

K Effah, E Tekpor, I Gedzah
High-risk HPV testing in first-void urine for cervical cancer screening: a clinical accurate alternative compared to cervical samples

S Van Keer, M Arbyn, A Vorsters
The self-sampling journey: technical considerations and challenges

L Connor, K Cuschieri, A Sargent
The effectiveness of HPV16/18 vaccination: managing the complexities of high-grade cervical intraepithelial neoplasia in cervical cancer screening

D Jenkins
HPV vaccination: the price of inaction

SJB Hanley, KT Simms, MA Smith

HOME
Published material
Remembering our colleagues
About us
Contact us

Login

Change email Change password Activate service

Did you forget your password?

Do you want to subscribe?

Legal notice Privacy Policy

Copyright © 2025 HPV World All rights reserved